UK Markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.3800+0.0800 (+2.42%)
At close: 04:00PM EDT
3.3800 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.45
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 37.9000
52-week low 31.9600
50-day moving average 32.7674
200-day moving average 34.1098

Share statistics

Avg vol (3-month) 3161.52k
Avg vol (10-day) 3164.75k
Shares outstanding 572.92M
Implied shares outstanding 6N/A
Float 831.61M
% held by insiders 116.08%
% held by institutions 159.01%
Shares short (14 Jul 2022) 41.42M
Short ratio (14 Jul 2022) 49.94
Short % of float (14 Jul 2022) 4N/A
Short % of shares outstanding (14 Jul 2022) 41.56%
Shares short (prior month 14 Jun 2022) 41.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)-7,494.75%

Management effectiveness

Return on assets (ttm)-29.23%
Return on equity (ttm)-51.13%

Income statement

Revenue (ttm)2.23M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-38.30%
Gross profit (ttm)-132.46M
EBITDA -158.14M
Net income avi to common (ttm)-145.89M
Diluted EPS (ttm)-2.2170
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)268.56M
Total cash per share (mrq)2.95
Total debt (mrq)19.25M
Total debt/equity (mrq)7.10
Current ratio (mrq)10.73
Book value per share (mrq)3.36

Cash flow statement

Operating cash flow (ttm)-115.55M
Levered free cash flow (ttm)-86.18M